SCHEMBL18979134

SCHEMBL18979134

CCSc1cc(C(F)(F)F)ccc1-c1ncc(-c2ccc(C(F)(F)F)cc2)n1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 2/20 0.45
POLB P06746 1/20 0.45
PTGDR2 Q9Y5Y4 1/20 0.36
DYRK1A Q13627 3/20 0.36
DYRK2 Q92630 3/20 0.36
DYRK3 O43781 2/20 0.36
CCNA2 P20248 2/20 0.36
CDK2 P24941 2/20 0.36
DYRK1B Q9Y463 2/20 0.36
DDR1 Q08345 2/20 0.35
CCNT1 O60563 1/20 0.35
CDK9 P50750 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
CYP1A2 P05177 3/20 0.33
SRC P12931 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19219730 0.95 MAPT (0.48) TP53GAAMAPTPOLBPTGDR2
SCHEMBL23169087 0.85 DDR1 (0.37) TP53GAAMAPTPOLBPTGDR2
SCHEMBL19017496 0.83 MC4R (0.38) POLBPTGDR2DDR1ALOX5APFEN1
SCHEMBL19017565 0.81 DDR1 (0.37) GAAMAPTPOLBPTGDR2DDR1
SCHEMBL18979181 0.80 HSD11B1 (0.50) TP53GAAMAPTPOLBDYRK1A
SCHEMBL30843064 0.80 MAPT (0.50) TP53GAAMAPTPOLBDYRK1A
SCHEMBL20544023 0.80 DDR1 (0.34) GAAMAPTPOLBPTGDR2DDR1
SCHEMBL20544024 0.80 DDR1 (0.34) GAAMAPTPOLBPTGDR2DDR1
SCHEMBL18751256 0.78 TP53 (0.44) TP53GAAMAPTPOLBPTGDR2
SCHEMBL23169086 0.78 S1PR1 (0.34) GAAPTGDR2DDR1ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220000112-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2022-01-06 US disclosed
EP-3766871-A1 DIARYLIMIDAZOLE COMPOUND AND PEST CONTROL AGENT Nippon Soda Co., Ltd. (JP) 2021-01-20 EP disclosed
EP-3766871-A1 DIARYLIMIDAZOLE COMPOUND AND PEST CONTROL AGENT Nippon Soda Co., Ltd. (JP) 2021-01-20 EP disclosed
EP-3181552-B1 DIARYL IMIDAZOLE COMPOUND AND PEST CONTROL AGENT NIPPON SODA CO (JP) 2020-10-21 EP disclosed
EP-3181552-B1 DIARYL IMIDAZOLE COMPOUND AND PEST CONTROL AGENT NIPPON SODA CO (JP) 2020-10-21 EP disclosed
CN-106573894-B Diaryl imidazole compound and pest control agent 日本曹达株式会社 2020-10-13 CN disclosed
US-20200187501-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2020-06-18 US disclosed
US-20200187501-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2020-06-18 US disclosed
US-20180289006-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2018-10-11 US disclosed
US-10021880-B2 Diarylimidazole compound and harmful organism control agent NIPPON SODA CO., LTD. (JP) 2018-07-17 US disclosed
US-10021880-B2 Diarylimidazole compound and harmful organism control agent NIPPON SODA CO., LTD. (JP) 2018-07-17 US disclosed
US-20170223958-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2017-08-10 US disclosed
US-20170223958-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2017-08-10 US disclosed
EP-3181552-A1 DIARYL IMIDAZOLE COMPOUND AND PEST CONTROL AGENT Nippon Soda Co., Ltd. (JP) 2017-06-21 EP disclosed
EP-3181552-A1 DIARYL IMIDAZOLE COMPOUND AND PEST CONTROL AGENT Nippon Soda Co., Ltd. (JP) 2017-06-21 EP disclosed
CN-106573894-A Diaryl imidazole compound and pest control agent 日本曹达株式会社 2017-04-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10021880-B2 Diarylimidazole compound and harmful organism control agent NOX1, L3MBTL1, MRM1 TP53 3609/4885GAA 3504/4885MAPT 4473/4885
US-20200187501-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NOX1, L3MBTL1, MRM1 TP53 3609/4885GAA 3504/4885MAPT 4473/4885
US-20180289006-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NOX1, L3MBTL1, MRM1 TP53 3609/4885GAA 3504/4885MAPT 4473/4885
US-20220000112-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NOX1, L3MBTL1, MRM1 TP53 3609/4885GAA 3504/4885MAPT 4473/4885
US-20170223958-A1 DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT NOX1, L3MBTL1, MRM1 TP53 3609/4885GAA 3504/4885MAPT 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.